It is highly expressed in the heart and lungs, particularly in alveolar epithelial cells in patients with COVID-19 and CVD and severe symptoms, in whom it might be associated with increased secretion of ACE2 compared to those without CVD [24]. Here, ACE2 is linked to COVID-19.